0000899243-20-013850.txt : 20200521 0000899243-20-013850.hdr.sgml : 20200521 20200521163116 ACCESSION NUMBER: 0000899243-20-013850 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200519 FILED AS OF DATE: 20200521 DATE AS OF CHANGE: 20200521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENDERSON MICHAEL THOMAS CENTRAL INDEX KEY: 0001779990 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 20902284 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-19 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001779990 HENDERSON MICHAEL THOMAS C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 0 1 0 0 Chief Business Officer Common Stock 2020-05-19 4 A 0 83541 0.00 A 245903 D Restricted Stock Units 2020-05-19 4 A 0 205000 0.00 A Common Stock 205000 205000 D Stock Option (Right to Buy) 0.28 2020-05-19 4 A 0 7335 0.00 A 2020-05-19 2027-11-13 Common Stock 7335 7335 D Stock Option (Right to Buy) 0.28 2020-05-19 4 A 0 1019 0.00 A 2020-05-19 2028-05-07 Common Stock 1019 1019 D Stock Option (Right to Buy) 0.16 2020-05-19 4 A 0 39487 0.00 A 2028-08-26 Common Stock 39487 39487 D Stock Option (Right to Buy) 4.13 2020-05-19 4 A 0 7778 0.00 A 2029-05-28 Common Stock 7778 7778 D Stock Option (Right to Buy) 1.65 2020-05-19 4 A 0 3351 0.00 A 2029-06-10 Common Stock 3351 3351 D Stock Option (Right to Buy) 4.22 2020-05-19 4 A 0 13932 0.00 A 2020-05-19 2029-09-24 Common Stock 13932 13932 D Stock Option (Right to Buy) 1.05 2020-05-19 4 A 0 45027 0.00 A 2020-05-19 2029-09-24 Common Stock 45027 45027 D Stock Option (Right to Buy) 2.29 2020-05-19 4 A 0 19271 0.00 A 2028-06-24 Common Stock 19271 19271 D Stock Option (Right to Buy) 1.05 2020-05-19 4 A 0 18365 0.00 A 2020-05-19 2029-12-17 Common Stock 18365 18365 D The shares were acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in privately-held subsidiaries of the Issuer (each, a "Subsidiary" and collectively, the "Subsidiaries"). Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date. 6.25% of the units will vest on August 16, 2020 and an additional 6.25% of the units will vest in quarterly installments on the 16th day of February, May, August and November until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its Subsidiaries through each applicable vesting date. The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio. 34,901 shares subject to the stock option were vested as of the date of acquisition, 1,246 shares shall vest May 22, 2020, and 3,340 shares shall vest in monthly installments over the next 3 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date. 5,654 shares subject to the stock option were vested as of the date of acquisition, 514 shares shall vest on May 29, 2020, and 1,610 shares shall vest in monthly installments over the next 4 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date. 2,030 shares shall vest and become exercisable on June 11, 2020, and 1,321 shares shall vest and become exercisable in monthly installments over the next 8 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date. 10,840 shares subject to the stock option were vested as of the date of acquisition, 402 shares shall vest on May 23, 2020, and 8,029 shares shall vest in monthly installments over the next 20 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date. /s/ Tara Condon, Attorney-in-Fact 2020-05-21